Protagonist Therapeutics Inc
PTGX
$144.88+0.80%
End of day · as of Oct 12, 2026, 8:00 PM ET
Mkt cap
$7.25B
EV/Sales
154.9
P/E ratio
N/A
FY2025 Revenue
$46.02M
EPS (H1 2026)
$2.35
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-282.83%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported PTGX revenue for 2025-12-31 was $46.0M. Net income was -$130.1M. Revenue was down 89.4% from 2024-12-31 to 2025-12-31. PTGX currently screens at market cap $7.25B.
Use this PTGX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full PTGX income, balance, and cash tables.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company in the Healthcare sector.
Latest cached Protagonist Therapeutics Inc (PTGX) revenue for Dec 31, 2025 was $46.0M. Net income was -$130.1M. Statements: https://lician.com/financials/ptgx
Protagonist Therapeutics Inc (PTGX) market capitalization is $7.25B on the latest cached snapshot.
Protagonist Therapeutics Inc (PTGX) cached previous close $143.73; day range $144.88 – $145.83; volume 898,504. Session quote: https://lician.com/quote/ptgx
Protagonist Therapeutics Inc (PTGX) latest cached earnings event is "PTGX earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached PTGX filing is 8-K · Jun 18, 2026. Filings: https://lician.com/sec/ptgx